Have cold-like symptoms? Contact Probe Clinical Research to learn whether you may qualify for our RSV study.
$75.00 PER STUDY VISIT FOR ELIGIBLE PARTICIPANTS
Screening includes testing for influenza A, influenza B, COVID-19, and RSV. People who test positive for RSV may qualify, subject to the study’s other eligibility requirements.
Participants are assigned by chance to receive either the investigational study medication (75% chance) or a placebo (25% chance). A placebo contains no active study medication. The investigational medication is being studied for RSV; benefit is not guaranteed.
Eligible participants receive $75 per study visit. Study-related testing and study medication are provided at no cost to participants.
Call 951-778-1131 to arrange screening or complete the study interest form below.
Study Interest Form
Advancing health through trusted clinical research.
